This funding will be awarded through open competition by
the National Institute for Health Research (NIHR), on
behalf of the Department of Health and Social Care (DHSC).
The purpose of this funding is to support capital
investment in buildings (including refurbishment) and
equipment to strengthen the UK’s AMRresearch capability in
order to:
- develop innovative approaches to
tackling AMR
- establish a body of researchers with a wide range of
skills and expertise relevant to AMR
- encourage external funding for AMR research
All NHS trusts, higher education institutions and
not-for-profit UK research organisations (including the NHS
and public sector agencies and research establishments) in
the UK are eligible to apply.
Funding will be awarded for a 2-year period starting on 1
April 2019. All funding provided to successful applicants
must be spent by 31 March 2021.
The closing date for applications is
1pm on 6 December 2018. More information is
on NIHR’s website.
Resistance to all antimicrobials, and especially bacterial
resistance to existing antibiotics, is increasing. It is
now posing a serious threat to health both in the UK and
globally, and risks undermining the major improvements in
medicine that have been made in recent decades.
Improving knowledge and understanding of AMR is an important
part of the UK’s AMR strategy. In
response to the independent review
on AMR, the government
set out what it would do to measure progress on
tackling AMRand committed
additional investment.
Chief Medical Officer, , said:
Without dedicated efforts to combat antimicrobial
resistance, modern medicine as we know it could be lost.
Funding new and innovative approaches to tackle the
problem is crucial, and this substantial capital funding
will be a significant step towards strengthening
UK-based AMR initiatives.
